391 related articles for article (PubMed ID: 17509718)
1. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
2. Pluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin delivery.
Xiong XY; Li QH; Li YP; Guo L; Li ZL; Gong YC
Colloids Surf B Biointerfaces; 2013 Nov; 111():282-8. PubMed ID: 23838194
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
4. Novel biodegradable and pH-sensitive poly(ester amide) microspheres for oral insulin delivery.
He P; Tang Z; Lin L; Deng M; Pang X; Zhuang X; Chen X
Macromol Biosci; 2012 Apr; 12(4):547-56. PubMed ID: 22362708
[TBL] [Abstract][Full Text] [Related]
5. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
7. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
Yang J; Sun H; Song C
Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
12. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
[TBL] [Abstract][Full Text] [Related]
14. Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
Jain S; Saraf S
J Diabetes; 2009 Mar; 1(1):29-35. PubMed ID: 20923517
[TBL] [Abstract][Full Text] [Related]
15. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
16. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
18. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
[TBL] [Abstract][Full Text] [Related]
19. Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters poly[vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly(L-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity.
Simon M; Behrens I; Dailey LA; Wittmar M; Kissel T
Eur J Pharm Biopharm; 2007 May; 66(2):165-72. PubMed ID: 17150341
[TBL] [Abstract][Full Text] [Related]
20. [The enhancing effect of tomato lectin modified liposomes of insulin on oral absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 May; 39(5):380-4. PubMed ID: 15338884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
